They discovered that rats administered nobiletin exhibited less cognitive impairment and lower levels of Toll-like receptor 4 (TLR4), NF-κB, and TNF-α but higher expression of Nrf2 in the hippocampus. Here, TLR4 is linked to Cognitive impairment.